Common Stock, Shares, Outstanding of LIGAND PHARMACEUTICALS INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
LIGAND PHARMACEUTICALS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • LIGAND PHARMACEUTICALS INC Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 19,774,000, a 3.5% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 19,774,000 +668,000 +3.5% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 19,656,000 +896,000 +4.8% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 19,411,000 +1,308,000 +7.2% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 19,276,000 +1,352,000 +7.5% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 19,106,000 +1,550,000 +8.8% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 18,760,000 +1,339,000 +7.7% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 18,103,000 +751,000 +4.3% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 17,924,000 +790,000 +4.6% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 17,556,000 +605,000 +3.6% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 17,421,000 +527,000 +3.1% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 17,352,000 +470,000 +2.8% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 17,134,000 +273,000 +1.6% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 16,951,000 +184,000 +1.1% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 16,894,000 +187,000 +1.1% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 16,882,000 +206,000 +1.2% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 16,861,000 +209,000 +1.3% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 16,767,000 +687,000 +4.3% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 16,707,000 +616,000 +3.8% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 16,676,000 +605,000 +3.8% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 16,652,000 +602,000 +3.8% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 16,080,000 -743,000 -4.4% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 16,091,000 -1,472,000 -8.4% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 16,071,000 -3,319,000 -17% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 16,050,000 -3,614,000 -18% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 16,823,000 -3,943,000 -19% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 17,563,000 -3,532,174 -17% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 19,390,000 -1,705,174 -8.1% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 19,664,000 -1,637,980 -7.7% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 20,766,000 -382,665 -1.8% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 21,095,174 +338 +0% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 21,095,174 +45,433 +0.22% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 21,301,980 +305,931 +1.5% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 21,148,665 +239,364 +1.1% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 21,094,836 +195,947 +0.94% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 21,049,741 +196,614 +0.94% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 20,996,049 +180,413 +0.87% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 20,909,301 +960,289 +4.8% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 20,898,889 +980,555 +4.9% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 20,853,127 +1,016,018 +5.1% 30 Jun 2016 10-Q 14 Nov 2016 2016 Q2
Q1 2016 20,815,636 +1,157,279 +5.9% 31 Mar 2016 10-Q 14 Nov 2016 2016 Q1
Q4 2015 19,949,012 +373,862 +1.9% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 19,918,334 -198,746 -0.99% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 19,837,109 -941,417 -4.5% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 19,658,357 -1,058,701 -5.1% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 19,575,150 -893,371 -4.4% 31 Dec 2014 10-K 14 Nov 2016 2015 FY
Q3 2014 20,117,080 -1,411,204 -6.6% 30 Sep 2014 10-Q 31 Oct 2014 2014 Q3
Q2 2014 20,778,526 -657,321 -3.1% 30 Jun 2014 10-Q 05 Aug 2014 2014 Q2
Q1 2014 20,717,058 -625,830 -2.9% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 20,468,521 -810,085 -3.8% 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 21,528,284 +445,606 +2.1% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 21,435,847 30 Jun 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 21,342,888 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 21,278,606 +596,100 +2.9% 31 Dec 2012 10-K/A 12 Dec 2014 2013 FY
Q3 2012 21,082,678 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q4 2011 20,682,506 31 Dec 2011 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.